IASLC Atlas of ALK and ROS1 Testing in Lung Cancer

Overview

These live webinars are intended to help pathologists, scientists and physicians better understand the background, protocol and interpretation of results of ALK and ROS1 testing for NSCLC patients. This webinar will: 

  • Introduce clinicians to the reference Atlas of Alk and ROS1 testing
  • Provide clinicians and scientists with a clear understanding of the background, testing protocols and interpretation of results of ALK and RPOS1 testing.
  • Identify and review the use of FISH (Fluoroescence In Situ Hybridization) and IHC (ImmunoHistoChemistry) to detect ALK.
Date
Sep 21, 2017 -
Sep 21, 2017
Location

Online

Prof. Keith Kerr
BSc, MB, ChB, FRCPath, FRCPE, Department of Pathology, Aberdeen University Medical School, Aberdeen Royal Infirmary, Aberdeen, UK.

Ming-Sound Tsao, MD, FRCPC
Senior Scientist, Princess Margaret Cancer Center\Professor of, Laboratory Medicine and Pathology, M. Qasim Choski Chair in Lung Cancer Translational Research, University of Toronto, Canada.

 

For any inquiries, please contact [email protected].

Prof. Keith Kerr
BSc, MB, ChB, FRCPath, FRCPE, Department of Pathology, Aberdeen University Medical School, Aberdeen Royal Infirmary, Aberdeen, UK.

Ming-Sound Tsao, MD, FRCPC
Senior Scientist, Princess Margaret Cancer Center\Professor of, Laboratory Medicine and Pathology, M. Qasim Choski Chair in Lung Cancer Translational Research, University of Toronto, Canada.

 

For any inquiries, please contact [email protected].

Share

Interested in advertising and exhibit opportunities?